...
首页> 外文期刊>Research journal of science and technology >Bulk Solution Assay Test Procedure Development and validation for Esomeprazole Sodium Injection 40mg as a CPP
【24h】

Bulk Solution Assay Test Procedure Development and validation for Esomeprazole Sodium Injection 40mg as a CPP

机译:批量溶液测定试验程序开发和验证EsomePrazole钠注射40mg作为CPP

获取原文
获取原文并翻译 | 示例
           

摘要

Assay analytical test procedure at the Bulk-Solution stage for Esomeprazole Sodium Injection 40mgas a Critical Processing Parameters during manufacturing developed and validated. As per current available literature and the references, Esomeprazole active substance is available in market in the five forms, i.e. Esomeprazole as Plain [Tablet]; Esomeprazole Magnesium Trihydrate [Tablet, Capsule Delayed Release]; Esomeprazole Potassium [Tablet and Capsule]; Esomeprazole Strontium [Capsule Delayed Release] and Esomeprazole Sodium [Injectable].Assay test procedure for Active and other dosage forms [Tablet, Capsule] were available based on either Potentiometric Titration or HPLC basis. Product Esomeprazole Sodium Injection 40mg is not available in official pharmacopeia. As per available reference and literature assay test method for intermediate testing and finished product is based on HPLC. Intermediate testing [In-Process Testing] required as Critical Process Parameters [CPP] to ensure the quality i.e. appropriate bulk-solution purity, before to proceed for filtration and filling of Bulk-solution in unit dosage form [Vials]. To test the bulk solution purity approximate 5-6 hours required by HPLC. Which leads to hold the Bulk solution, further it impact and may risk to Bio-Burden of bulk solution. Also it impact and reduce the productivity of line by 5-6 hours. HPLC testing required special skilled manpower and cost. Considering all above concerns Study carried for test method development based on UV-Spectroscopy, HPLC and potentiometric titration. Based on method validation performed for UV-Spectrometry, HPLC and potentiometric titration; Test procedure developed and validated based on UV-Spectrometry is found Simple, Accurate, Precise, Economical and Rapid to save time and cost with increase in productivity as a Critical Processing Parameters for Esomeprazole Sodium Injection 40mgat the Bulk-Solution stage during manufacturing.
机译:在制造和验证的制造过程中,测定蒸汽唑钠注射液的体溶液阶段的分析试验程序40mgas临界处理参数。根据当前可用的文献和参考文献,eSomePrazole活性物质可在五种形式的市场上提供,即EsomePrazole作为平原[平板电脑]; eSomeprazole镁三水合物[平板电脑,胶囊延迟释放]; eSomeprazole钾[平板电脑和胶囊]; EsomePrazole锶[胶囊延迟释放]和eSomeprazole钠[可注射]。基于电位滴定或HPLC,可用的活性和其他用量的活性和其他用量的测试程序[片剂,胶囊]。产品eSomePrazole钠注射液40mg在官方药典中不可用。根据可用的参考和文献测定试验方法,用于中间测试和成品基于HPLC。作为关键过程参数[CPP]所需的中间测试[内部工艺测试]以确保适当的散装溶液纯度,以进行过滤和填充单位剂型[小瓶]的散装溶液。测试散装溶液纯度近似HPLC所需的5-6小时。这导致占批量解决方案,进一步影响,可能会对散装溶液的生物负担影响。它也会影响并降低5-6小时的生产率。 HPLC测试需要特殊熟练的人力和成本。考虑到以上所有涉及基于UV光谱,HPLC和电位滴定的测试方法开发的研究。基于对UV光谱,HPLC和电位滴定进行的方法验证;基于UV光谱法开发和验证的测试程序简单,准确,精确,经济且快速,以节省时间和成本,随着蒸汽哌唑钠注射40mgAT在制造期间的批量溶液阶段的批判性处理参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号